Suchergebnisse - "Sellers, Edward M"

PubPharm (235)

1

Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?

enthalten in: Clinical pharmacology in drug development | 2024

von Sellers, E. | Romach, M.

CommentOn: Clin Pharmacol Drug Dev. 2024 Jan;13(1):58-69. - PMID 37496452

2

Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?

enthalten in: Clinical Pharmacology in Drug Development | 2024

von Sellers, E. | Romach, M.

3

Psychedelics : Science sabotaged by Social Media

enthalten in: Neuropharmacology | 2023

von Sellers, E. | Romach, M.

4

Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats : Evidence for an Antidepressant Property

enthalten in: Frontiers in pharmacology | 2021

von Higgins, G. | Carroll, N. | Brown, M. | +7

5

5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence

enthalten in: Progress in brain research | 2021

von Higgins, G. | Sellers, E.

6

Identification of Optimal Measures of Human Abuse Potential : A Post Hoc Assessment of 19 Studies

enthalten in: Journal of clinical psychopharmacology | 2020

von Shram, M. | Levy-Cooperman, N. | Ratcliffe, S. | +6

7

Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users : A randomized, double-blind, controlled trial

enthalten in: Epilepsy & behavior : E&B | 2018

von Schoedel, K. | Szeto, I. | Setnik, B. | +5

8

Studies with psychedelic drugs in human volunteers

enthalten in: Neuropharmacology | 2018

von Sellers, E. | Romach, M. | Leiderman, D.

9

Categorization of Abuse Potential-Related Adverse Events

enthalten in: Clinical pharmacology in drug development | 2018

von Sellers, E. | Romach, M.

10

Opioids : The Painful Public Health Reality

enthalten in: Clinical pharmacology and therapeutics | 2018

von Tyndale, R. | Sellers, E.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]